Oscar Health, Inc. (NYSE:OSCR – Get Free Report) insider Adam Mcananey sold 9,092 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $285,943.40. Following the sale, the insider owned 209,004 shares of the company’s stock, valued at $6,573,175.80. This trade represents a 4.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Oscar Health Price Performance
Shares of NYSE OSCR opened at $32.53 on Friday. The stock has a fifty day moving average price of $30.58 and a 200 day moving average price of $23.27. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $33.55. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. The company has a market cap of $10.04 billion, a PE ratio of 23.24, a P/E/G ratio of 0.65 and a beta of 2.37.
Oscar Health (NYSE:OSCR – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.70. The company had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. Oscar Health’s revenue was up 70.4% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.89) EPS. Sell-side analysts forecast that Oscar Health, Inc. will post 1.54 EPS for the current year.
Hedge Funds Weigh In On Oscar Health
Analysts Set New Price Targets
Several research analysts recently issued reports on the stock. The Goldman Sachs Group reissued a “neutral” rating and set a $30.00 price target on shares of Oscar Health in a report on Tuesday, August 11th. Wells Fargo & Company lifted their price objective on Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a report on Thursday, August 13th. Piper Sandler reiterated an “overweight” rating and set a $36.00 target price on shares of Oscar Health in a research report on Tuesday, July 28th. Wall Street Zen raised Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. Finally, Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, Oscar Health currently has an average rating of “Hold” and a consensus price target of $26.22.
Check Out Our Latest Report on OSCR
Oscar Health Company Profile
Oscar Health, Inc is a technology-focused health insurance company that offers health plans and related services to individuals, families and small businesses in the United States. The company’s primary business is providing Individual and Family plans through the Affordable Care Act marketplaces, along with health insurance options for small-group employers in select markets.
Oscar combines insurance coverage with digital tools designed to help members manage their care. Its offerings include online and mobile enrollment, virtual care, provider search and navigation services, claims and benefits information, and access to care teams.
Featured Articles
- Five stocks we like better than Oscar Health
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
